Net Loss of Astec Lifesciences reported to Rs 15.70 crore in the quarter ended December 2025 as against net loss of Rs 40.38 crore during the previous quarter ended December 2024. Sales rose 32.88% to Rs 124.72 crore in the quarter ended December 2025 as against Rs 93.86 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales124.7293.86 33 OPM %3.19-6.12 - PBDT-2.37-13.75 83 PBT-13.59-25.15 46 NP-15.70-40.38 61 Powered by Capital Market - Live News

Astec Lifesciences will hold a meeting of the Board of Directors of the Company on 30 January 2026.Powered by Capital Market - Live News

Net Loss of Astec Lifesciences reported to Rs 24.43 crore in the quarter ended September 2025 as against net loss of Rs 38.56 crore during the previous quarter ended September 2024. Sales declined 25.20% to Rs 73.72 crore in the quarter ended September 2025 as against Rs 98.55 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales73.7298.55 -25 OPM %-9.07-20.03 - PBDT-13.97-27.07 48 PBT-24.41-38.54 37 NP-24.43-38.56 37 Powered by Capital Market - Live News

Net Loss of Astec Lifesciences reported to Rs 24.45 crore in the quarter ended September 2025 as against net loss of Rs 38.57 crore during the previous quarter ended September 2024. Sales declined 25.20% to Rs 73.72 crore in the quarter ended September 2025 as against Rs 98.55 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales73.7298.55 -25 OPM %-9.05-20.01 - PBDT-13.99-27.08 48 PBT-24.45-38.57 37 NP-24.45-38.57 37 Powered by Capital Market - Live News

Astec Lifesciences will hold a meeting of the Board of Directors of the Company on 29 October 2025.Powered by Capital Market - Live News